Several gene sets that were positively enriched with obesity were also enriched in FGF1-treated MCF7 TAMR cells, including glycolysis (Fig. 9E), suggesting that obesity supports an environment of endocrine therapy resistance in ER-positive breast cancer, potentially prior to treatment. The gene discussed is FGF1; the disease is obesity due to melanocortin 4 receptor deficiency.